Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHS2100020	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2021-02-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2021-02-11	view
JXHS2100022	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2021-02-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2021-02-11	view
JXHS2100021	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2021-02-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2021-02-11	view
JXHS2300069	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(5.1)	Import Drug Application	2023-07-17					view
JYHB2300308	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2023-05-25					view
JYHB2300309	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2023-05-25					view
JYHB2400535	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2024-10-11					view
JXHS2300070	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(5.1)	Import Drug Application	2023-07-14					view
JYHB2400536	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2024-10-11					view
JXHS2300071	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(5.1)	Import Drug Application	2023-07-14					view
JYHB2400534	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2024-10-11					view
JYHB2300307	阿布昔替尼片	abrocitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2023-05-25					view